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Abstract
Background: At diagnosis, 16% of rheumatoid arthritis (RA) patients may have foot joint
involvement, increasing to 90% as disease duration increases. This can lead to joint instability,
difficulties in walking and limitation in functional ability that restricts activities of daily living. The
podiatrist plays an important role in the multidisciplinary team approach to the management of foot
problems. The aim of this study was to undertake a clinical audit of foot problems in patients with
RA treated at Counties Manukau District Health Board.
Methods: Patients with RA were identified through rheumatological clinics run within CMDHB.
100 patients were eligible for inclusion. Specific foot outcome tools were used to evaluate pain,
disability and function. Observation on foot lesions were noted and previous history of foot
assessment, footwear/insoles and foot surgery were evaluated.
Results: The median age of the cohort was 60 (IQR: 51–64) years old with median disease
duration of 15 (IQR: 7.3–25) years. Over 85% presented with foot lesions that included corns and
callus over the forefoot region and lesser toe deformities. Moderate to high disability was noted.
High levels of forefoot structural damage were observed. 76% had not seen a podiatrist and 77%
reported no previous formal foot assessment. 40% had been seen at the orthotic centre for
specialised footwear and insoles. 27% of RA patients reported previous foot surgery. A large
proportion of patients wore inappropriate footwear.
Conclusion: This clinical audit suggests that the majority of RA patients suffer from foot problems.
Future recommendations include the provision of a podiatrist within the current CMDHB
multidisciplinary rheumatology team to ensure better services for RA patients with foot problems.
Introduction
Rheumatoid arthritis (RA) is the most common type of
inflammatory arthritis [1]. The prevalence rate of RA in
New Zealand has been reported to be between 0.79–2.6%
[2,3]. When untreated, the disease can progress rapidly,
causing swelling and damage to cartilage and bone
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wrists and feet are most often involved [4].
The main symptoms of RA are severe pain, stiffness,
fatigue and loss of mobility. 42% of RA patients are regis-
tered disabled within 3 yrs of diagnosis [2]. 80% are mod-
erately to severely disabled within 20 yrs. At diagnosis,
16% of RA patients may have foot joint involvement [5]
increasing to 90% as disease duration increases [5,6]. This
can lead to joint instability, difficulties in walking and
limitation in functional ability that restricts activities of
daily living [6]. The talo-navicular joint is the most com-
monly affected; subtalar joint involvement shows a simi-
lar pattern, with an increase of 25% between 5–10 years
of duration [7]. Deformity of the tarsal joints and forefoot
also occurs with disease progression [8].
Williams and Bowden [9] reported that the evidence base
for dedicated podiatry as part of multidisciplinary foot
clinics in diabetes is well established, but that this has yet
to be achieved for rheumatology services [10]. However,
the role of the podiatrist in the rheumatology team is
becoming recognised as a vital component in the inte-
grated care given to patients by the multidisciplinary team
[11,12]. Increasingly consultants and their teams are
requesting specialist foot care services and it is suggested
that the podiatrist is a key practitioner in the management
of patients with musculoskeletal disease [11-13]. It has
been recommended that patients should understand the
role and have access to a podiatrist [9]. The podiatrist's
role is to identify, diagnose and treat disorders, diseases
and deformities of the feet and legs and implement appro-
priate and timely care. Additionally, podiatrists also mon-
itor foot health status, provide education and support in
enabling behaviour change in lifestyle, and may be the
only health-care professional that the patient sees on a
regular basis. Therefore, they may arguably act as gate-
keepers to other members of the multi-disciplinary team.
This may be provided directly by a podiatrist or in associ-
ation with other healthcare team members as required by
the individual's foot problems [4].
The goal of the podiatry element of rheumatology care is
to reduce foot-related pain, maintain/improve foot func-
tion and thus mobility, while protecting skin and other
tissues from damage [4]
Despite this recognition, it is generally perceived that
access to podiatry services for patients with rheumatic dis-
eases appears to be varied and in some instances absent,
especially in New Zealand. Podiatrists have a prominent
role to play in symptom relief and improving quality of
life because involvement of the feet, even to a mild degree,
is a significant marker for impaired mobility, functional
incapacity and negative psychosocial impact. Foot pathol-
ogy contributes to difficulty with walking in about 75% of
people with RA, and is the main or only cause of walking
difficulty in 25% [1]. In the foot, joint pain and stiffness
is the most common initial presentation, but a range of
other features, including tenosynovitis, nodule formation
and tarsal tunnel syndrome may also present, reflecting
widespread soft-tissue involvement [13,14].
Based upon the Arthritis and Musculoskeletal Alliance
(ARMA) Standards of Care for People with Foot Health
Problems and Inflammatory Arthritis [15] the purpose of
this audit is to provide a benchmark by which podiatric
service standards may be evaluated by all stakeholders.
Therefore, the aim of this study is to identify the nature of
foot problems experienced by patients attending rheuma-
tology outpatient clinics at Counties Manukau District
Health Board (CMDHB) and to ascertain the availability
of podiatric services for these patients.
Method
Patients
The clinical audit was conducted over 12 weeks between
December 2008 and March 2009. Sample size was deter-
mined by a fixed recruitment period for this clinical audit.
Ethical approval was obtained from the Northern
Regional Ethics Committee. All patients received informa-
tion regarding the study. A convenience sample of 100 RA
patients was recruited from rheumatology outpatient serv-
ices based at CMDHB, Auckland, New Zealand. One
examiner (JC) interviewed and assessed all patients.
Patients were eligible if they had a confirmed diagnosis of
RA (satisfying the 1987 American Rheumatism Associa-
tion revised criteria [16].
Demographic characteristics
Age, ethnicity, gender, occupation, disease duration,
Health Assessment Questionnaire (HAQ) [17] and cur-
rent pharmacological management that includes non-
steroidal anti-inflammatory drugs (NSAIDs), methotrex-
ate, other disease modifying anti-rheumatic drugs
(DMARDs), prednisone and biologic therapies were
recorded for each patient. Blood results that included
erythrocyte sedimentation rate (ESR), C-reactive protein
(CRP) and the presence of radiographic erosions were
recorded from the patient's case notes.
Foot and ankle assessment
Foot and ankle assessment were based upon the recom-
mendations from the Standards of Care for People with
Musculoskeletal Foot Health Problems [16]. Assessments
included:
(i) Measures of structure and function;Page 2 of 7
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(iii) Footwear suitability;
(iv) Tissue viability and skin and nail assessments;
(v) Baseline measures of foot impairment;
(vi) The impact of any previous interventions, includ-
ing surgery and foot orthoses.
The musculoskeletal foot examination included docu-
mentation of foot and toe deformities, foot type, joint
swelling, pain and instability, plantar callus and foot
ulceration. Baseline measures of pain, function and health
status were also assessed [12,17].
Procedure
Fore- and rearfoot deformities were quantified using the
Structural Index score [18], which considers hallux valgus,
metatarsal phalangeal (MTP) subluxation, 5th MTP exos-
tosis, and claw/hammer toe deformities for the forefoot
(range 0–12) and calcaneus valgus/varus angle, ankle
range of motion and pes planus/cavus deformities for the
rearfoot (range 0–7). Lesser toe deformities (hammer,
mallet, and claw toes) were scored one point each, as were
hyperkeratotic lesions (corns and calluses). Other abnor-
mal bony prominences, such as Tailor's bunions and
exostoses, were also scored one point [19]. Patients were
asked if they received professional foot care and what
interventions were used (such as palliative care, foot
orthoses or specialist footwear). Similarly those patients
who had been provided with foot orthoses by the local
orthotic centre were asked about the suitability of the
devices and if they had been beneficial in reducing foot
pain. Finally, the assessing podiatrist asked if the patients'
had undergone previous foot surgery.
Disease measurement
Disease impact was measured using the Leeds Foot Impact
Scale [12]. This self completed questionnaire comprises
two subscales for impairment/footwear (LFISIF) and
activity limitation/participation restriction (LFISAP). The
former contains 21 items related to foot pain and joint
stiffness as well as footwear related impairments and the
latter contains 30 items related to activity limitation and
participation restriction [12].
Footwear characteristics
An objective assessment of footwear was carried out by the
podiatrist, to ascertain the type and appropriateness of the
participant's footwear. The assessment included shoe
style: selected from a list of 16 basic shoe styles and
included the terms sandals, mules and jandals [20]. San-
dals are defined as shoes consisting of a sole fastened to
the foot by thongs or straps. A mule shoe is a type of shoe
that is backless and often closed-toed. The term jandals,
used predominantly in New Zealand and the South
Pacific (also known as flip-flops in the UK and US and
thongs in Australia) are flat, backless, usually rubber san-
dal consisting of a flat sole held loosely on the foot by a Y-
shaped strap that passes between the first and second toes
and around either side of the foot.
Data analysis
Data were analysed using SPSS 15.0 for Windows. Phar-
macological management, gender, occupation, ethnicity
and general footwear scores were described as percent-
ages. All other demographic characteristics were described
as the median (interquartile range – IQR).
Results
Participant demographics and disease characteristics
One hundred (100) RA patients were recruited into the
study with a median age of 60 (IQR: 51–64) years old
with 79% being women. The results demonstrated a ratio
of 4:1 female: males (Table 1). Fifty-seven patients (57%)
were Caucasian with 14% being Maori and 14% Pacific
Islanders. The median duration of disease was 15 (IQR:
7.3–25) years which suggests a well-established disease
with levels of functional disability. In spite of the general
prevalence of moderate disease activity, 39% of patients
were employed.
Sixteen percent (16%) of patients also had diabetes Sixty-
seven percent (67%) of patients presented with erosions
on X-rays. Sixty-four percent (64%) of patients were
treated with NSAIDs, 67% specifically with methotrexate,
42% with other DMARDs, 33% with prednisone and 17%
with biologic therapies.
Foot impairments
Patients in the current study had high-to severe (LFISIF >7
point, LFISAP >10 points) levels of foot impairment and
disability on the LFIS subscales (Table 2). The forefoot
structural index demonstrated severe structural problems
but the rearfoot structural indices demonstrated moderate
problems. Over two-thirds of patients were observed with
hallux valgus (bunions). Over 85% of patients in the
study presented with symptomatic callus under the
plantar surface of the foot and/or on the toes.
Podiatric care
Concerning podiatric intervention, 24% of RA patients
reported they have been seen by a podiatrist and over 40%
of patients used the orthotic centre. Because of the
absence of a podiatry service at CMDHB for patients other
than those with diabetes, no participant in the current
study had received podiatric intervention by a qualified
podiatrist specialising in the management of rheumaticPage 3 of 7
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(Table 2). The majority of RA patients wore open-type
footwear such as sandals (21%), jandals (10%) or mules
(10%). Only nine patients wore surgical footwear (Table
3).
Discussion
The purpose of this study was to undertake a clinical audit
evaluating current RA foot care services in Counties Manu-
kau. Overall, this study demonstrates that in this particu-
lar outpatient clinic, poor foot health and foot pain is
highly prevalent in patients with rheumatic diseases. Over
85% of patients with RA had foot involvement ranging
from callus, corns and lesser toe deformities. The study
also demonstrated moderate impairment and limited
activity using the Leeds Foot Impact Scale [12] suggesting
the majority of patients suffer with long-term disability
from this chronic condition.
Table 1: Demographic & clinical characteristics
Demographic characteristics Value
Median (IQR) Age (years) 60 (51–64)
% Gender (F:M) 4:1 (79% females, 21% males)
% Ethnicity Caucasian: 57%,
Pacific Island 14%,
Maori: 14%,
Asian: 11%,
Non-European Caucasian: 4%
Median (IQR) disease duration (years) 15 (7.3–25)
Working: (%) 34%
Not working/Beneficiary: (%) 15%
Retired: (%) 31%
Housewife/homemaker: (%) 15%
Clinical characteristics
Median (IQR) HAQ Score (0–3) 0.9 (0.4, 1.3)
% radiographic erosions Yes: 67%; No: 33%
Pharmacological management
NSAIDS: n (%) 62 (64%)
Methotrexate: n (%) 65 (67%)
Other DMARDS: n (%) 41 (42%)
Prednisone: n (%) 32 (33%)
Biologics: n (%) 17 (17%)
Blood investigations
Median (IQR) ESR (mg/hr) 27.0 (12.0; 42.3)
Median (IQR) CRP (mm/L) 7.9 (3.8; 7.3)Page 4 of 7
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majority of patients were observed wearing footwear that
could be described as inappropriate for those patients
with severe pain and disability and included sandals,
mules and jandals. The lack of support mechanisms, cush-
ioning and protection of toe regions may contribute to
pain and disability.
The current clinical audit demonstrated 16% of RA
patients presented with diabetes suggesting that patients
with autoimmune disorders, and/or taking medication
that compromises the immune system should be consid-
ered at risk of infection and foot ulceration, due to a lack
of protection, especially on the plantar surface of the feet.
Likewise, patients with micro-vascular and/or large vessel
disease and foot deformity are also at risk of foot trauma,
ulceration and subsequent infection [9]. The use of podi-
atrists and management programmes that includes advice
of foot health education, appropriate footwear and pre-
scription of foot orthoses is essential if we are to reduce
the impact of foot problems in this patient group.
The results from the current audit are similar to UK audits
[3,9]. Recent reports from the UK recommend the need
for more consistent provision of specialist care for
patients with RA and better implementation of guidance
and best practice [4,21]. However, there is no similar data
or recommendations for New Zealand, and there are no
previous studies of foot problems in New Zealand
patients with rheumatic diseases.
The results of this study support the case for a specialist
podiatrist to manage patients with rheumatic diseases in
this locality, whatever the patient's age or stage of disease.
This audit recommends that in order to identify patients
with foot problems, their consultant or specialist nurse
should question patients about their feet. If foot problems
are identified, a referral to the specialist podiatrist should
be made. Patients with disabling foot pain, or who are at
risk of foot ulceration, should receive priority foot care
[9,22]. Foot orthoses should be considered for patients
recently diagnosed with RA as this intervention has been
Table 2: Foot & ankle characteristics
Foot characteristics Score
Median (IQR) Forefoot Structural Index (range 0–12) 9 (4–14)
Median (IQR) Rearfoot Structural Index (range 0–7) 2 (2–4)
Median (IQR) Leeds Foot Impact Scale impairment/footwear (range 0–21) 11 (8–14)
Median (IQR) Leeds Foot Impact Scale activity limitation/participation restriction (range 22–51) 18 (11–23)
Total Median (IQR) Leeds Foot Impact Scale 29 (20–36)
Median (IQR) Foot Problem Score 7 (5–13)
Hallux Valgus: (%) 64%
Number and Frequency of Foot Lesions: n (%) 99 (79%)
Forefoot Callus: (%) 63%
Lesser Toe Deformities: (%) 86%
Previous Foot Assessment: n (%) Yes: (23%)
No: (77%)
Previous Podiatry: n (%) Yes: (24%)
No: (76%)
Previous Foot Surgery: n (%) Yes: (27%)
No: (73%)
Previous Orthotics: n (%) Yes: (40%)
No: (60%)Page 5 of 7
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joint function in the foot [23].
The current audit demonstrated that RA patients reported
podiatry was "very useful". However, patients perception
of the term podiatry was related only to toenail cutting,
and corn reduction rather than for structural modifica-
tions. The role of the podiatrist within rheumatology
involves a range of different assessments and interven-
tions [4]. An assessment of the lower limbs may include
the skin, vascular and neurological systems, the muscu-
loskeletal structures and walking. Specialist prescription
footwear should also be available for patients who cannot
fit into appropriate retail footwear and in this domain;
both podiatrists and orthotists should collaborate to
achieve the optimal clinical outcome [9]. Working with
surgeons, in relation to appropriateness for foot surgery,
should also be considered, as this option is often over-
looked by podiatrists. This study demonstrates that there
is an unmet need for specialist podiatry in patients attend-
ing this particular rheumatology outpatient clinic. A
mechanism should be in place whereby everyone with a
diagnosis of inflammatory arthritis receives a foot exami-
nation within three months of diagnosis [16].
Patients with RA should be provided with information
and education to enable them to recognise the signs of
these variations and understand what to do if variations
occur. Increased systemic disease activity can accelerate
changes in foot pathology so consideration must be taken
of local as well as systemic factors. A recent study under-
taken in the UK using a self-management foot care pro-
gramme for 30 patients with RA demonstrated that just
over 50% of patients were physically able to undertake
some aspects of self-managed foot care, including nail
clipping and filing, callus filing and daily hygiene and
inspection [13]. A clinical audit of 139 rheumatoid
patients undertaken in the UK reported that poor foot
health and foot pain as being common in patients with
rheumatic diseases [9]. The authors highlighted that the
lack of foot care could lead to reduction in mobility and
in some cases serious complications and recommended
that a specialist and dedicated foot care service needs to be
provided for these patients [9].
Conclusion
The current study has highlighted patients with RA have
an increased need for a range of basic foot care services.
There is evidence from the current literature that early
intervention for existing or potential foot problems can
improve long-term outcomes. Baseline foot examination
can identify people with existing or imminent needs and
provide a comparator for assessment. Regular assessments
that document the rate of structural change can aid treat-
ment decisions and improves outcomes. An annual mus-
culoskeletal, vascular and neurological assessment, which
includes an assessment of the lower limbs and feet, will
help identify problems early. Future developments may
incorporate self-educational programmes and the need
for podiatrists to be part of the rheumatological multidis-
ciplinary team. Overall, this study showed that opportuni-
ties for innovation and improvement in RA services exist
and need to be pursued vigorously including the develop-
ment of a business case for a combined DHB-academic
post in podiatry.
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Table 3: General footwear assessment
General footwear type %
Sandal 21%
Mule 13%
Jandals 10%
Walking Shoe 10%
Athletic Shoe 9%
Moccasin 9%
Surgical/Orthotic Shoe 9%
Boot 6%
High Heel 4%
Backless Slipper 2%
Court Shoe 2%
Oxford Shoe 2%
Socks only 1%
Slipper 1%
Unable to assess footwear 1%Page 6 of 7
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